TNF and rheumatoid arthritis: A meticulously planned synthesis process was employed to create a lipid nanoparticle system capable of simultaneously encapsulating hydroxychloroquine, a commonly utilized small-molecular drug in rheumatoid arthritis treatment, and siRNA directed against TNF-α.